WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy

Linda J. W. Bosch, Yanxin Luo, Victoria V. Lao, Petur Snaebjornsson, Geert Trooskens, Ilse Vlassenbroeck, Sandra Mongera, Weiliang Tang, Piri Welcsh, James G. Herman, Miriam Koopman, Iris D. Nagtegaal, Cornelis J. A. Punt, Wim van Criekinge, Gerrit A. Meijer, Raymond J., Jr. Monnat, Beatriz Carvalho, William M. Grady

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)4612-4622
JournalClinical Cancer Research
Volume22
Issue number18
DOIs
Publication statusPublished - 15 Sep 2016

Cite this

Bosch, Linda J. W. ; Luo, Yanxin ; Lao, Victoria V. ; Snaebjornsson, Petur ; Trooskens, Geert ; Vlassenbroeck, Ilse ; Mongera, Sandra ; Tang, Weiliang ; Welcsh, Piri ; Herman, James G. ; Koopman, Miriam ; Nagtegaal, Iris D. ; Punt, Cornelis J. A. ; van Criekinge, Wim ; Meijer, Gerrit A. ; Monnat, Raymond J., Jr. ; Carvalho, Beatriz ; Grady, William M. / WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy. In: Clinical Cancer Research. 2016 ; Vol. 22, No. 18. pp. 4612-4622.
@article{b4dcdddbb59e4a57b1959f4982d7fe6a,
title = "WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy",
author = "Bosch, {Linda J. W.} and Yanxin Luo and Lao, {Victoria V.} and Petur Snaebjornsson and Geert Trooskens and Ilse Vlassenbroeck and Sandra Mongera and Weiliang Tang and Piri Welcsh and Herman, {James G.} and Miriam Koopman and Nagtegaal, {Iris D.} and Punt, {Cornelis J. A.} and {van Criekinge}, Wim and Meijer, {Gerrit A.} and Monnat, {Raymond J., Jr.} and Beatriz Carvalho and Grady, {William M.}",
year = "2016",
month = "9",
day = "15",
doi = "10.1158/1078-0432.CCR-15-2703",
language = "English",
volume = "22",
pages = "4612--4622",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "18",

}

Bosch, LJW, Luo, Y, Lao, VV, Snaebjornsson, P, Trooskens, G, Vlassenbroeck, I, Mongera, S, Tang, W, Welcsh, P, Herman, JG, Koopman, M, Nagtegaal, ID, Punt, CJA, van Criekinge, W, Meijer, GA, Monnat, RJJ, Carvalho, B & Grady, WM 2016, 'WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy' Clinical Cancer Research, vol. 22, no. 18, pp. 4612-4622. https://doi.org/10.1158/1078-0432.CCR-15-2703

WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy. / Bosch, Linda J. W.; Luo, Yanxin; Lao, Victoria V.; Snaebjornsson, Petur; Trooskens, Geert; Vlassenbroeck, Ilse; Mongera, Sandra; Tang, Weiliang; Welcsh, Piri; Herman, James G.; Koopman, Miriam; Nagtegaal, Iris D.; Punt, Cornelis J. A.; van Criekinge, Wim; Meijer, Gerrit A.; Monnat, Raymond J., Jr.; Carvalho, Beatriz; Grady, William M.

In: Clinical Cancer Research, Vol. 22, No. 18, 15.09.2016, p. 4612-4622.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy

AU - Bosch, Linda J. W.

AU - Luo, Yanxin

AU - Lao, Victoria V.

AU - Snaebjornsson, Petur

AU - Trooskens, Geert

AU - Vlassenbroeck, Ilse

AU - Mongera, Sandra

AU - Tang, Weiliang

AU - Welcsh, Piri

AU - Herman, James G.

AU - Koopman, Miriam

AU - Nagtegaal, Iris D.

AU - Punt, Cornelis J. A.

AU - van Criekinge, Wim

AU - Meijer, Gerrit A.

AU - Monnat, Raymond J., Jr.

AU - Carvalho, Beatriz

AU - Grady, William M.

PY - 2016/9/15

Y1 - 2016/9/15

U2 - 10.1158/1078-0432.CCR-15-2703

DO - 10.1158/1078-0432.CCR-15-2703

M3 - Article

VL - 22

SP - 4612

EP - 4622

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 18

ER -